Auge v. Stryker Corporation

CourtDistrict Court, D. New Mexico
DecidedAugust 2, 2021
Docket1:14-cv-01089
StatusUnknown

This text of Auge v. Stryker Corporation (Auge v. Stryker Corporation) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Auge v. Stryker Corporation, (D.N.M. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW MEXICO

WAYNE KENNETH AUGE, II, M.D., Individually and as Trustee on Behalf of Covalent Global Trust, Plaintiff, Vs. CV No. 14-1089 KG/SMV STRYKER CORPORATION, and HOWMEDICA OSTEONICS CORP., Defendants.

ORDER GRANTING IN PART AND DENYING IN PART PLAINTIFF’S MOTION IN LIMINE This matter is before the Court on Plaintiff's Motion in Limine Number 2 to Exclude Testimony of Karl Leinsing (Motion) (Doc. 350) and Defendants’ Opposition to Plaintiff's Motion in Limine Number 2 to Exclude Testimony of Karl Leinsing (Response) (Doc. 363). In his Motion, Plaintiff challenges the qualifications of Defendants’ expert Karl Leinsing, in addition to the relevance and reliability of his conclusions. (Doc. 350) at 4-11. The Court has sufficient evidence to evaluate Mr. Leinsing’s testimony without a hearing. See Dodge v. Cotter Corp., 328 F.3d 1212, 1228 (10th Cir. 2003) (explaining that “district court has discretion to limit the information upon which it will decide the Daubert issue”). After review of the parties’ briefing and the relevant law, the Court grants in part and denies in part Plaintiff's Motion (Doc. 350).

L Background Defense expert Karl Leinsing is a licensed professional engineer with over 26 U.S. patents for medical device products. (Doc. 363-1) at 2. Aside from inventing medical products, Mr. Leinsing also serves as the President of ATech Designs, Inc., a medical device product development and consulting company. /d. Over the years, Mr. Leinsing has been recognized by the National Professional Engineering Society, the Governor of North Carolina, and LIFE Magazine for his award-winning design developments. Jd. In addition, Mr. Leinsing served as a chairman for the medical device product development conference in Anaheim, California, and teaches continuing education courses on medical device product development. Jd. Related to this case specifically, Mr. Leinsing has experience “develop[ing] a mitral valve repair device that required a flexible drill...” Jd. at 3. After being hired by defense counsel, Mr. Leinsing reviewed the patents at issue to ascertain whether Defendants’ products fit within the ambit of the parties’ negotiated agreement. Id. at 7. In pertinent part, Mr. Leinsing’s report “discusses and compares [Plaintiff's] disclosures to prior art references” to determine whether they were otherwise “publicly available” and, thus, not subject to the controlling contract. Jd. at 7-9. Based on this analysis, Mr. Leinsing concludes that Defendants’ products should not be considered “improvements to Confidential Information” as prohibited by the parties’ agreement. Jd. at 15. Similarly, Mr. Leinsing concludes that Plaintiffs patents do not cover Defendants’ current products at the center of the parties’ dispute. Id. at 16. Now, Plaintiff requests that the Court exclude several portions of Mr. Leinsing’s report, challenging both his qualifications to serve as an expert in federal court and the reliability of his opinions. See (Doc. 350).

IL. Standard Federal Rule of Evidence 702 governs the admissibility of expert testimony, directing that: If scientific, technical, or other specialized knowledge will assist the trier of fact to understand the evidence or to determine a fact in issue, a witness qualified as an expert by knowledge, skill, experience, training, or education, may testify thereto in the form of an opinion or otherwise, if (1) the testimony is based upon sufficient facts or data, (2) the testimony is the product of reliable principles and methods, and (3) the witness has applied the principles and methods reliably to the facts of the case. Under Rule 702, a district court must conduct a two-step “gatekeeping” analysis to determine the admissibility of expert opinions. Kumho Tire., Ltd. v. Carmichael, 526 U.S. 137, 147 (1999) (citing Daubert v. Merrell Dow Pharms. Inc., 509 U.S. 579 (1993)); Milne v. USA Cycling, Inc., 575 F.3d 1120, 1134 (10th Cir. 2009). First, a court must assess whether the expert is “qualified,” by ascertaining their “knowledge, skill, experience, training, or education.” LifeWise Master Funding v. Telebank, 374 F.3d 917, 928 (10th Cir. 2004) (citing Fed. R. Evid. 702). For an expert to be deemed qualified under the Federal Rules, their testimony must be “relevant” to the issues before the court. Daubert, 509 U.S. at 591. Second, a court must determine whether the expert’s opinion is “reliable.” Jd. at 593-94. An expert’s opinion must be both relevant and reliable to be admissible. Milne, 575 F.3d at 1134. The party that proffers the expert testimony bears the burden of proving its compliance with Rule 702 by a preponderance of the evidence. Fed. R. Evid. 702 Advisory Committee Notes (2000) (citing Fed. R. Evid. 104(a)). Nonetheless, a court should liberally admit expert testimony. United States v. Gomez, 67 F.3d 1515, 1526 (10th Cir. 1995) (citing Daubert, 509 U.S. at 588). Furthermore, a court is afforded broad “discretion in determining the competency of an expert.” Jd. at 1525 (internal citation omitted).

II. Discussion In his Motion, Plaintiff offers four bases to exclude Mr. Leinsing’s proposed opinions. See (Doc. 350) at 1. First, Plaintiff contends that Mr. Leinsing’s opinions “improperly invade the role of the jury.” Jd. Second, Plaintiff argues that Mr. Leinsing’s opinions are not relevant to the facts at issue. Jd. Third, Plaintiff asserts that Mr. Leinsing’s opinions are nothing more than “unsupported ipse dixit.” Id. Fourth and, finally, Plaintiff contends that Mr. Leinsing is unqualified to proffer an expert opinion on the issues before the jury. Jd. The Court addresses each of Plaintiff's contentions in turn. A. Whether Mr. Leinsing’s Opinions “Invade the Role of the Jury” Plaintiff first alleges that three of Mr. Leinsing’s proposed opinions “improperly invade the role of the jury.” (Doc. 350) at 1. Specifically, Plaintiff contests the admissibility of Mr. Leinsing’s opinions concerning: (1) “the meaning of the February 2000 Confidentiality Agreement;” (2) “whether Defendants’ conduct was permissible under the February 2000 Confidentiality Agreement;” and (3) “the meaning of [Plaintiffs] deposition testimony.” Jd. at 4-6, 11-12. In support of his first two challenges to Mr. Leinsing’s opinion, Plaintiff argues that Mr. Leinsing attempts to improperly tell the jury what conclusion to reach, rather than assist them in understanding a fact at issue. Jd. at 6. In response, Defendants agree to withdraw their request to elicit testimony from Mr. Leinsing regarding the scope of the February 2000 Confidentiality Agreement. (Doc. 363) at 3. Particularly, Defendants explain that Mr. Leinsing’s expert report was “served in March 2017, long before the Court’s summary judgment order dated May 11, 2018.” Jd. □□ □ n. 1. Prior to the Court’s May 2018 ruling, the factfinder’s interpretation of the February 2000 Confidentiality Agreement was a central issue surrounding Plaintiffs claims. Jd. at 3-4. Now,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
United States v. Guardia
135 F.3d 1326 (Tenth Circuit, 1998)
Ralston v. Smith & Nephew Richards, Inc.
275 F.3d 965 (Tenth Circuit, 2001)
Lifewise Master Funding v. Telebank
374 F.3d 917 (Tenth Circuit, 2004)
Norris v. Baxter Healthcare Corp.
397 F.3d 878 (Tenth Circuit, 2005)
United States v. Rodriguez-Felix
450 F.3d 1117 (Tenth Circuit, 2006)
Milne v. USA Cycling Inc.
575 F.3d 1120 (Tenth Circuit, 2009)
United States v. Lupe Gomez
67 F.3d 1515 (Tenth Circuit, 1995)
Bitler v. A.O. Smith Corp.
400 F.3d 1227 (Tenth Circuit, 2005)
United States v. Ibarra-Diaz
805 F.3d 908 (Tenth Circuit, 2015)
Taber v. Allied Waste Systems, Inc.
642 F. App'x 801 (Tenth Circuit, 2016)
Gardner v. General Motors Corp.
507 F.2d 525 (Tenth Circuit, 1974)

Cite This Page — Counsel Stack

Bluebook (online)
Auge v. Stryker Corporation, Counsel Stack Legal Research, https://law.counselstack.com/opinion/auge-v-stryker-corporation-nmd-2021.